BRAINLIFE.ORG
|
|
|
|
|
Current
Neuro-Oncology
|
|
|
|
Volume
25 Number 4
28 February 2023
|
|
|
|
Home
>
Publications
>
Current
Neuro-Oncology >
Volume
25, Year 2023 >
Number
4, 28 February
|
|
|
|
|
°
|
Joerger M,
Hundsberger T, Haefliger S, von Moos R, Hottinger AF, Kaindl T,
Engelhardt M, Marszewska M, Lane H, Roth P, Stathis A.
Safety
and anti-tumor activity of lisavanbulin administered as 48-hour
infusion in patients with ovarian cancer or recurrent
glioblastoma: a phase 2a study.
Invest
New Drugs. 2023 Feb 16∟.
doi: 10.1007/s10637-023-01336-9∟.
PMID: 36792805∟.
Interventional study. ˍ
|
|
|
|
Tuna G, Bekar
NED, İşlekel S, İşlekel GH.
Urinary
8-hydroxy-2'-deoxyguanosine levels are elevated in patients with
IDH1-wildtype glioblastoma and are associated with tumor
recurrence in gliomas.
DNA
Repair (Amst). 2023 Feb 16;124:103463∟.
doi: 10.1016/j.dnarep.2023.103463∟.
PMID: 36841018∟.
Laboratory investigation˰ ˍ
|
|
|
°
|
Agar MR,
Nowak AK, Hovey EJ, Barnes EH, Simes J, Vardy JL, Wheeler HR, Kong
BY, Leonard R, Hall M, Tim E, Spyridopoulos D, Sim HW, Lwin Z,
Dowling A, Harrup R, Jennens R, Kichenadasse G, Dunlop T, Gzell C,
Koh ES.
Acetazolamide
versus placebo for cerebral oedema requiring dexamethasone in
recurrent and/or progressive high-grade glioma: phase II
randomised placebo-controlled double-blind study.
BMJ
Support Palliat Care. 2023 Feb 17:spcare-2022-004119∟.
doi: 10.1136/spcare-2022-004119∟.
PMID: 36807048∟.
Interventional study˰ ˍ
|
|
|
|
Goldsmith HS.
Introduction of
chemotherapy by omentum for a glioblastoma WHO-IV.
Surg
Neurol Int. 2023 Feb 17;14:59∟.
doi: 10.25259/SNI_1080_2022∟.
PMID: 36895220∟.
Editorial. ˍ
|
|
|
|
Yang C, Li
ZQ, Wang J.
Association
between systemic immune-inflammation index (SII) and survival
outcome in patients with primary glioblastoma.
Medicine
(Baltimore). 2023 Feb 17;102(7):e33050∟.
doi: 10.1097/MD.0000000000033050∟.
PMID: 36800573∟.
Observational study. ˍ
|
|
|
|
Shen F, Li J, Liu F, Sun N, Qiu X, Ding W, Sun X.
The
efficacy and adverse effects of anlotinib in the treatment of
high-grade glioma: A retrospective analysis.
Front
Oncol. 2023 Feb 17;13:1095362∟.
doi: 10.3389/fonc.2023.1095362∟.
PMID: 36874124∟.
Observational study. ˍ
|
|
|
°
|
Waqar M,
Roncaroli F, Djoukhadar I, Akkari L, O'Leary C, Hewitt L, Forte G,
Jackson R, Hessen E, Withington L, Beasley W, Richardson J, Golby
C, Whitehurst P, Colaco R, Bailey M, Karabatsou K, D'Urso PI,
McBain C, Coope DJ, Borst GR.
Study
protocol: PreOperative Brain Irradiation in Glioblastoma (POBIG) -
A phase I trial.
Clin
Transl Radiat Oncol. 2023 Jan 18;39:100585∟.
doi: 10.1016/j.ctro.2023.100585∟.
PMID: 36845633∟.
Interventional study protocol. ˍ
|
|
|
°
|
Dunkel IJ, Doz F, Foreman NK,
Hargrave D, Lassaletta A, André N, Hansford JR, Hassall T,
Eyrich M, Gururangan S, Bartels U, Gajjar A, Howell L, Warad D,
Pacius M, Tam R, Wang Y, Zhu L, Cohen K.
Nivolumab
With or Without Ipilimumab in Pediatric Patients With High-Grade
CNS Malignancies: Safety, Efficacy, Biomarker, and
Pharmacokinetics: CheckMate 908.
Neuro
Oncol. 2023 Feb 20:noad031∟.
doi: 10.1093/neuonc/noad031∟.
PMID: 36808285∟.
Interventional
study. ˍ
|
|
|
|
Glavatskyi
OY, Griazov AB, Chuvashova OY, Kruchok IV, Griazov AA,
Khmelnytskyi HV, Shuba IM, Stuley VA, Zemskova OV.
Radiosurgical
treatment of recurrent glioblastoma and prognostic factors
affecting treatment outcomes.
Exp
Oncol. 2023 Feb 20, 2022;44(4):307-313∟.
doi: 10.32471/exp-oncology.2312-8852.vol-44-no-4.18920∟.
PMID: 36811543∟.
Observational study. ˍ
|
|
|
|
Rykkje AM,
Larsen VA, Skjøth-Rasmussen J, Nielsen MB, Carlsen JF,
Hansen AE.
Timing
of Early Postoperative MRI following Primary Glioblastoma
Surgery-A Retrospective Study of Contrast Enhancements in 311
Patients.
Diagnostics
(Basel). 2023 Feb 20;13(4):795∟.
doi: 10.3390/diagnostics13040795∟.
PMID: 36832282∟.
Observational study. ˍ
|
|
|
|
Bigagli E, Agostiniani S, Pugi A, Rombi B, Tornaboni EE, Censullo
ML, Gori CG, Pavone R, Sardi I.
Unforeseen
cytomegalovirus retinopathy following high dose thiotepa and
proton irradiation in a pediatric patient with high-risk
medulloblastoma: A case report.
Front
Pediatr. 2023 Feb 21;11:1145941∟.
doi: 10.3389/fped.2023.1145941∟.
PMID: 36896395∟.
Case report. ˍ
|
|
|
|
Ibn Essayed W, Jarvis CA, Bernstock JD, Slingerland A, Albanese J,
Friedman GK, Arnaout O, Baird L.
Positioning
Transclival Tumor-Treating Fields for the Treatment of Diffuse
Intrinsic Pontine Gliomas.
Life
(Basel). 2023 Feb 21;13(3):601∟.
doi: 10.3390/life13030601∟.
PMID: 36983757∟.
Observational study. ˍ
|
|
|
*
|
Liu Y, Li L, Hu H, Yang J, Zhang X, Chen L, Chen F, Hao S, Li W,
Huang G.
Association between
preoperative hematocrit and postoperative 30-day mortality in
adult patients with tumor craniotomy.
Front
Neurol. 2023 Feb 21;14:1059401∟.
doi: 10.3389/fneur.2023.1059401∟.
PMID: 36895901∟.
Observational study. ˍ
|
|
|
|
Veronese S,
Bertocchi E, Lissoni B, Rudà R, Silvani A, Simonetti G,
Pisanello A, Ieraci S, Salmaggi A, Merli R, Verza M, De Panfilis
L, Solari A, Pace A.
Patient
and carer involvement in the formulation of research questions:
findings from the Italian guideline on palliative care in adults
with glioma.
Neurol
Sci. 2023 Feb 21∟.
doi: 10.1007/s10072-023-06687-y∟.
PMID: 36809422∟.
Interviews˰ ˍ
|
|
|
|
Xiao D, Yan C, Li D, Xi T, Liu X, Zhu D, Huang G, Xu J, He Z, Wu
A, Ma C, Long J, Shu K, Ji H, Wang N, Chen G, Yang J, Ma H, Li Z,
Sun X, Qu Y, Liu Z, Jiang X, Tian C, Ni S, Zhan R, Chen L, Ge M,
Wang M, Jiang X, Guo G, Han Z, Zhang C, Zhang T, Dou C, Chu L,
Wang P, Shao J, Wu X, Yu J, Wang Y, Wu N, Zhang R, Zhang M, Hong
Y, Gao J, Li Y, Pan Y, Zhao B, Ji N, Shan G, Patel CB, Jia W,
Zhang L.
National Brain Tumour Registry
of China (NBTRC) statistical report of primary brain tumours
diagnosed in China in years 2019-2020.
Lancet
Reg Health West Pac. 2023 Feb 21;34:100715∟.
doi: 10.1016/j.lanwpc.2023.100715∟.
PMID: 37283963∟.
Observational study. ˍ
|
|
|
|
Elia A,
Bertuccio A, Vitali M, Barbanera A, Pallud J.
Is
surgical resection predict overall survival in frail patients with
glioblastoma, IDH-wildtype?
Neurochirurgie.
2023 Feb 22;69(2):101417∟.
doi: 10.1016/j.neuchi.2023.101417∟.
PMID: 36827763∟.
Observational study˰ ˍ
|
|
|
|
Ladenhauf VK, Galijasevic M, Kerschbaumer J, Freyschlag CF,
Nowosielski M, Birkl-Toeglhofer AM, Haybaeck J, Gizewski ER,
Mangesius S, Grams AE.
Peritumoral ADC
Values Correlate with the MGMT Methylation Status in Patients with
Glioblastoma.
Cancers
(Basel). 2023 Feb 22;15(5):1384∟.
doi: 10.3390/cancers15051384∟.
PMID: 36900177∟.
Observational study. ˍ
|
|
|
|
Smolenschi C,
Rassy E, Pallud J, Dezamis E, Copaciu R, Parker F, Garcia G,
Lezghed N, Colomba E, Khettab M, Ammari S, Fekhi M, Martanovschi
L, Benadhou L, Knafo S, Guyon D, Cheaib B, Dhermain F, Dumont
SN.
Bevacizumab
in real-life patients with recurrent glioblastoma: benefit or
futility?
J
Neurol. 2023 Feb 22∟.
doi: 10.1007/s00415-023-11600-w∟.
PMID: 36813928∟.
Observational study˰ ˍ
|
|
|
|
Zhang C, Zhong X, Yi L, Zhao Z, Zhang Y, Tan G, Zhang Y, Zhang Y,
Xu Y, Wu N.
Exploring the Associations
between Alzheimer's Disease and GBM Mediated by Microglia Based on
Network Analysis.
J
Prev Alzheimers Dis. 2023 Feb 22;10(2):267-275∟.
doi: 10.14283/jpad.2023.23∟.
PMID: 36946454∟.
Laboratory
investigation˰ ˍ
|
|
|
|
Ambulkar R, Parab SY, Vignesh B, Nagargoje V, Janu A, Parikh P,
Moiyadi A.
A prospective study to
evaluate the use of surveillance venous ultrasonography to detect
incidence of deep venous thrombosis following neurosurgical
excision of brain tumors.
J
Neurosci Rural Pract. 2023 Feb 23;14(2):252-257∟.
doi: 10.25259/JNRP_26_2022∟.
PMID: 37181162∟.
Interventional
study. ˍ
|
|
|
|
Huang WH,
Huang TY, Lin CM, Mu PF, Lee YY, Liu SH, Hsu SM, Chen YW.
Salvage
boron neutron capture therapy for pediatric patients with
recurrent diffuse midline glioma.
Childs
Nerv Syst. 2023 Feb 23∟.
doi: 10.1007/s00381-023-05850-2∟.
PMID: 36821007∟.
Observational study˰ ˍ
|
|
|
|
Matsuda M,
Mizumoto M, Kohzuki H, Sugii N, Sakurai H, Ishikawa E.
High-dose
proton beam therapy versus conventional fractionated radiation
therapy for newly diagnosed glioblastoma: a propensity score
matching analysis.
Radiat
Oncol. 2023 Feb 23;18(1):38∟.
doi: 10.1186/s13014-023-02236-1∟.
PMID: 36823671∟.
Observational study. ˍ
|
|
|
|
Krishnatry R,
Mani S, Manjali JJ, Rane PP, Chatterjee A, Goda JS, Janu A, Sahu
A, Gupta T, Jalali R.
Institutional
Patterns of Care of Diffuse Intrinsic Pontine Glioma.
Neurol
India. 2023 Feb 24;71(1):72-78∟.
doi: 10.4103/0028-3886.370459(?). PMID: 36861577∟.
Observational study. ˍ
|
|
|
|
Malhotra KP,
Kaif M, Malhotra HS, Husain N.
A
Novel Case of Primary Conus Medullaris Epithelioid Glioblastoma
with Gliosarcomatous Differentiation.
Neurol
India. 2023 Feb 24;71(1):132-134∟.
doi: 10.4103/0028-3886.370454(?) PMID: 36861587∟.
Case report. ˍ
|
|
|
|
Sangeeta T,
Prerana R, Kumar AA, Amarnath J.
Simultaneous
Amino Acid PET/MRI - An Opportunity to Assess True Response in
Recurrent High-Grade Glioma after Antiangiogenic Therapy.
Neurol
India. 2023 Feb 24;71(1):158-159∟.
doi: 10.4103/0028-3886.370455(?) PMID: 36861599∟.
Letter to the editor, Case report. ˍ
|
|
|
*
|
Shahab SW, Schniederjan M, Vega JV, Little S, Reisner A, MacDonald
T, Aguilera D.
Case report: ATIC-ALK
fusion in infant-type hemispheric glioma and response to
lorlatinib.
Front
Oncol. 2023 Feb 24;13:1123378∟.
doi: 10.3389/fonc.2023.1123378∟.
PMID: 36910660∟.
Case report. ˍ
|
|
|
|
Park YW, Han
K, Kim S, Kwon H, Ahn SS, Moon JH, Kim EH, Kim J, Kang SG, Chang
JH, Kim SH, Lee SK.
Revisiting
prognostic factors in glioma with leptomeningeal metastases: a
comprehensive analysis of clinical and molecular factors and
treatment modalities.
J
Neurooncol. 2023 Feb 25∟.
doi: 10.1007/s11060-022-04233-y∟.
PMID: 36841906∟.
Observational study. ˍ
|
|
|
|
Romo CG,
Piotrowski AF, Campian JL, Diarte J, Rodriguez FJ, Bale TA, Dahiya
S, Gutmann DH, Lucas CG, Prichett L, Mellinghoff I, Blakeley
JO.
Clinical,
Histological and Molecular Features of Gliomas in Adults with
Neurofibromatosis Type 1.
Neuro
Oncol. 2023 Feb 25:noad033∟.
doi: 10.1093/neuonc/noad033∟.
PMID: 36840626∟.
Observational study˰ ˍ
|
|
|
|
Zhu P, Du XL,
Hwang LY, Lairson D, Li R, Esquenazi Y, Zhu JJ.
Impact
of timing to initiate adjuvant therapy on survival of elderly
glioblastoma patients using the SEER-Medicare and national cancer
databases.
Sci
Rep. 2023 Feb 25;13(1):3266∟.
doi: 10.1038/s41598-023-30017-z∟.
PMID: 36841851∟.
Observational study. ˍ
|
|
|
|
Waqar U, Ali IFM, Farooqui I, Ahmad S, Chaudhry AA, Angez M,
Ziauddin A, Shamim MS.
The effect of
preoperative steroids for at least 10 days on complications
following craniotomy for tumor resection: A database,
retrospective cohort study.
Brain
Spine. 2023 Feb 26;3:101725∟.
doi: 10.1016/j.bas.2023.101725∟.
PMID: 37383460∟.
Observational study. ˍ
|
|
|
|
Aftahy AK, Butenschoen VM, Hoenikl
L, Liesche-Starnecker F, Wiestler B, Schmidt-Graf F, Meyer B,
Gempt J.
A
rare case of H3K27-altered diffuse midline glioma with multiple
osseous and spinal metastases at the time of diagnosis.
BMC
Neurol. 2023 Feb 28;23(1):87∟.
doi: 10.1186/s12883-023-03135-4∟.
PMID: 36855102∟.
Case
report. ˍ
|
|
|
|
Tringale KR, Wolden SL, Karajannis M, Haque S, Pasquini L,
Yildirim O, Rosenblum M, Benhamida JK, Cheung NK, Souweidane M,
Basu EM, Pandit-Taskar N, Zanzonico PB, Humm JL, Kramer
K.
Outcomes of intraventricular
131-I-omburtamab and external beam radiotherapy in patients with
recurrent medulloblastoma and ependymoma.
J
Neurooncol. 2023 Feb 28∟.
doi: 10.1007/s11060-022-04235-w∟.
PMID: 36853490∟.
Interventional study. ˍ
|
|
|
|
|
|
|
|
|
|
|